Erratum: Genetic variants in IL15 associate with progression of joint destruction in rheumatoid arthritis: a multicohort study (Ann Rheum Dis (2012) 71 (1651-7) DOI: 10.1136/annrheumdis-2011-200724);Genetic variants in IL15 associate with progression of joint destruction in rheumatoid arthritis: A multicohort study

Annals of the Rheumatic Diseases

Volumn 71, Issue 10, 2012, Pages 1651-1657

  Knevel, Rachel ^a   Krabben, A ^a   Brouwer, E ^b   Posthumus, M D ^b   Wilson, A G ^c   Lindqvist, E ^d   Saxne, T ^d   De Rooy, D ^a   Daha, N ^a   Van Der Linden, M P M ^a   Stoeken, G ^a   Van Toorn, L ^a   Koeleman, B ^e   Tsonaka, R ^a   Zhernakoza, A ^a   Houwing Duistermaat, J J ^a   Toes, R ^a   Huizinga, T W J ^a   Van Der Helm van Mil, A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d LUND UNIVERSITY   (Sweden)

^e Complex Genetics Section ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 15;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; IL15 GENE; IMMUNOPATHOGENESIS; JOINT DESTRUCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84866062778     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2011-200724corr1     Document Type: Erratum

References (27)

1. de Rooy DP, van der Linden MP, Knevel R, et al. Predicting arthritis outcomes - what can be learned from the Leiden Early Arthritis Clinic? Rheumatology (Oxford) 2011;50:93-100.
2. van der Helm-van Mil AH, Kern M, Gregersen PK, et al. Variation in radiologic joint destruction in rheumatoid arthritis differs between monozygotic and dizygotic twins and pairs of unrelated patients. Arthritis Rheum 2006;54:2028-30.
3. Asquith DL McInnes IB. Emerging cytokine targets in rheumatoid arthritis. Curr Opin Rheumatol 200719:246-51.
4. Wilkinson PC, Liew FY. Chemoattraction of human blood T lymphocytes by interleukin-15. J Exp Med 1995;181:1255-9.
5. McInnes IB, al-Mughales J, Field M, et al. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat Med 1996;2:175-82.
6. Kuca-Warnawin E, Burakowski T, Kurowska W, et al. Elevated number of recently activated T cells in bone marrow of patients with rheumatoid arthritis: a role for interleukin 15? Ann Rheum Dis 2011;70:227-33.
7. McInnes IB, Liew FY. Interleukin 15: a proinflammatory role in rheumatoid arthritis synovitis. Immunol Today 1998;19:75-9.
8. Ferrari-Lacraz S, Zanelli E, Neuberg M, et al. Targeting IL-15 receptor-bearing cells with an antagonist mutant IL-15/Fc protein prevents disease development and progression in murine collagen-induced arthritis. J Immunol 2004;173:5818-26.
9. Djaafar S, Pierroz DD, Chicheportiche R, et al. Inhibition of T cell-dependent and RANKL-dependent osteoclastogenic processes associated with high levels of bone mass in interleukin-15 receptor-deficient mice. Arthritis Rheum 2010;62:3300-10.
10. Petrovic-Rackov L, Pejnovic N. Clinical significance of IL-18, IL-15, IL-12 and TNF-alpha measurement in rheumatoid arthritis. Clin Rheumatol 2006;25:448-52.
11. van der Heijde D. How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 2000;27:261-3.
12. Mewar D, Coote A, Moore DJ, et al. Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis. Arthritis Res Ther 2006;8:R128.
13. Rau R, Herborn G. A modified version of Larsen's scoring method to assess radiologic changes in rheumatoid arthritis. J Rheumatol 1995;22:1976-82.
14. Fex E, Jonsson K, Johnson U, et al. Development of radiographic damage during the first 5-6 yr of rheumatoid arthritis. A prospective follow-up study of a Swedish cohort. Br J Rheumatol 1996;35:1106-15.
15. Lindqvist E, Jonsson K, Saxne T, et al. Course of radiographic damage over 10 years in a cohort with early rheumatoid arthritis. Ann Rheum Dis 2003;62:611-6.
16. Larsen A, Dale K. Standardized radiological evaluation of rheumatoid arthritis in therapeutic trials. In: Dumonde DC, Jasani MK, eds. The recognition of antirheumatic drugs. Lancaster: MTP Press, 1978:285-92.
17. Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5.
18. https://www.wtccc.org.uk
19. Strand V, Landéwé R, van der Heijde D. Using estimated yearly progression rates to compare radiographic data across recent randomised controlled trials in rheumatoid arthritis. Ann Rheum Dis 2002;61:ii64-6.
20. van der Helm-van Mil AH, Knevel R, van der Heijde D, et al. How to avoid phenotypic misclassification in using joint destruction as an outcome measure for rheumatoid arthritis? Rheumatology (Oxford) 2010;49:1429-35.
21. Lassere M. Pooled metaanalysis of radiographic progression: comparison of Sharp and Larsen methods. J Rheumatol 2000;27:269-75.
22. Lebrec JJ, Stijnen T, van Houwelingen HC. Dealing with heterogeneity between cohorts in genomewide SNP association studies. Stat Appl Genet Mol Biol 2010;9:Article 8.
23. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 1995;57:289-300.
24. Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science 2002;296:2225-9.
25. Pincus T, Larsen A, Brooks RH, et al. Comparison of 3 quantitative measures of hand radiographs in patients with rheumatoid arthritis: Steinbrocker stage, Kaye modified Sharp score, and Larsen score. J Rheumatol 1997;24:2106-12.
26. Waldmann TA, Tagaya Y. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu Rev Immunol 1999;17:19-49.
27. Fehniger TA, Caligiuri MA. Interleukin 15: biology and relevance to human disease. Blood 2001;97:14-32.